Valneva SE (VALN) Change in Intangibles (2021 - 2026)
Valneva SE's (VALN) quarterly Change in Intangibles came in at -$5853.7 in Q1 2026, up 92.16% year-on-year from -$3046.2 in Q1 2025, and down 151.71% quarter-over-quarter from $11319.6 in Q2 2025.
Valneva SE (VALN) Change in Intangibles (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Change in Intangibles across 6 years of filings, most recently posting -$5853.7 for Q1 2026.
- Change in Intangibles for Q1 2026 came in at -$5853.7, up 92.16% year-over-year; the trailing twelve-month figure through Mar 2026 was -$69217.9 (up 97.76% YoY), and the FY2024 annual result was -$2.8 million, down 3062.22% from the prior year.
- Change in Intangibles came in at -$5853.7 for Q1 2026 at Valneva SE, down from $11319.6 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $13.0 million in Q3 2023 to a low of -$13.1 million in Q2 2023.
- The 5-year median for Change in Intangibles is -$45189.5 (2023), against an average of -$299935.7.
- Peak annual rise in Change in Intangibles reached 17835.25% in 2024, while the deepest fall reached 184.34% in 2024.
- Valneva SE's Change in Intangibles stood at -$85297.7 in 2022, then jumped by 47.02% to -$45189.5 in 2023, then soared by 17835.25% to $8.0 million in 2024, then plunged by 99.86% to $11319.6 in 2025, then plunged by 151.71% to -$5853.7 in 2026.
- The last three Change in Intangibles figures came in at -$5853.7 (Q1 2026), $11319.6 (Q2 2025), and -$74683.8 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Intangibless (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | -5,853.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,853.73 |
| Mar 31, 2026 | -5,853.73 |
| Jun 30, 2025 | 11,319.60 |
| Jun 30, 2025 | 11,319.60 |
| Mar 31, 2025 | -74,683.80 |
| Mar 31, 2025 | -74,683.80 |
| Dec 31, 2024 | 8.01 Mn |
| Dec 31, 2024 | 8.01 Mn |
| Sep 30, 2024 | -10.98 Mn |
| Sep 30, 2024 | -10.98 Mn |
| Jun 30, 2024 | -48,459.94 |
| Jun 30, 2024 | -48,459.94 |
| Mar 31, 2024 | -36,936.30 |
| Mar 31, 2024 | -36,936.30 |
| Dec 31, 2023 | -45,189.48 |
| Dec 31, 2023 | -45,189.48 |
| Sep 30, 2023 | 13.02 Mn |
| Sep 30, 2023 | 13.02 Mn |
| Jun 30, 2023 | -13.07 Mn |
| Jun 30, 2023 | -13.07 Mn |